Clinical trial
A Double-blind Randomized Clinical Trial of the Efficacy of IM Midazolam Versus IV Lorazepam in the Pre-hospital Treatment of Status Epilepticus by Paramedics
NCT00809146 is registered in ClinicalTrials.gov with Robert Silbergleit as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-blind Randomized Clinical Trial of the Efficacy of IM Midazolam Versus IV Lorazepam in the Pre-hospital Treatment of Status Epilepticus by Paramedics
- Lead sponsor
- Robert Silbergleit
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 30, 2009
- Completion date
- January 31, 2011
- Enrollment
- 1,023 (actual)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.